Teva to serve as defendant in bellwether trial alleging generic drug price-fixing

Teva Pharmaceuticals will serve as the defendant in a bellwether trial over an alleged industrywide scheme to fix generic drug prices, a Pennsylvania judge ruled July 13.

The bellwether trial will serve to determine if numerous lawsuits filed against generic drugmakers should be combined into a class-action case.